TWM
ABBV icon

Triton Wealth Management’s AbbVie ABBV Stock Holding History

Triton Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$461K Sell
1,824
-47
-3% -$10.1K 0.14% 75
2026
Q1 		$402K Buy
1,871
+3
+0.2% +$665 0.15% 77
2025
Q4 		$422K Buy
1,868
+85
+5% +$19.4K 0.16% 77
2025
Q3 		$389K Sell
1,783
-7
-0.4% -$1.43K 0.15% 75
2025
Q2 		$342K Buy
+1,790
New +$333K 0.15% 80
2024
Q4 		$277K Hold
1,376
– – 0.14% 74
2024
Q3 		$271K Sell
1,376
-59
-4% -$11K 0.15% 70
2024
Q2 		$249K Sell
1,435
-6
-0.4% -$994 0.15% 73
2024
Q1 		$243K Buy
1,441
+201
+16% +$34.6K 0.17% 66
2023
Q4 		$201K Buy
+1,240
New +$181K 0.13% 69

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Triton Wealth Management's ABBV Position: Q2 2026 in Review

Triton Wealth Management reduced its AbbVie (ABBV) stake by 2.5% in Q2 2026, selling an estimated $10.1K and leaving 1,824 shares worth $461K. The position accounts for 0.14% of the portfolio, ranked #75.

Triton Wealth Management first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Triton Wealth Management held 1,824 shares of AbbVie worth $461K as of Q2 2026.
  • Triton Wealth Management sold 47 AbbVie shares in Q2 2026, an estimated $10.1K.
  • AbbVie made up 0.14% of Triton Wealth Management's portfolio in Q2 2026, its #75 holding.
  • Triton Wealth Management first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Triton Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.